vs
丹纳赫（DHR）与Truist Financial（TFC）财务数据对比。点击上方公司名可切换其他公司
丹纳赫的季度营收约是Truist Financial的1.6倍（$6.0B vs $3.7B），Truist Financial净利率更高（36.6% vs 17.3%，领先19.3%），丹纳赫同比增速更快（3.7% vs 3.1%），过去两年Truist Financial的营收复合增速更高（4.8% vs 1.8%）
丹纳赫是总部位于美国华盛顿特区的医疗健康企业，聚焦生物技术、生命科学与诊断领域的产品研发。公司下设三大业务板块：生物技术板块开发治疗相关产品，生命科学板块覆盖疾病溯源、新疗法研发、药物疫苗与基因编辑技术的测试生产，诊断板块研发检测仪器，为全球生命健康产业提供核心支持。
Truist Financial是美国银行控股公司，总部位于北卡罗来纳州夏洛特，2019年12月由BB&T与SunTrust合并组建。旗下银行在15个州及华盛顿特区共运营1928家网点，提供零售、商业、投资银行、证券经纪、资产管理、抵押贷款、保险等多元金融产品服务，为美国第十大银行，总资产达5230亿美元。
DHR vs TFC — 直观对比
营收规模更大
DHR
是对方的1.6倍
$3.7B
营收增速更快
DHR
高出0.6%
3.1%
净利率更高
TFC
高出19.3%
17.3%
两年增速更快
TFC
近两年复合增速
1.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $6.0B | $3.7B |
| 净利润 | $1.0B | $1.4B |
| 毛利率 | 60.3% | — |
| 营业利润率 | 22.6% | 42.3% |
| 净利率 | 17.3% | 36.6% |
| 营收同比 | 3.7% | 3.1% |
| 净利润同比 | 7.9% | 6.1% |
| 每股收益（稀释后） | $1.45 | $1.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DHRTFC
| Q1 26 | $6.0B | — | ||
| Q4 25 | $6.8B | $3.7B | ||
| Q3 25 | $6.1B | $3.6B | ||
| Q2 25 | $5.9B | $3.6B | ||
| Q1 25 | $5.7B | $3.5B | ||
| Q4 24 | $6.5B | $3.6B | ||
| Q3 24 | $5.8B | $3.6B | ||
| Q2 24 | $5.7B | $3.5B |
净利润DHRTFC
| Q1 26 | $1.0B | — | ||
| Q4 25 | $1.2B | $1.4B | ||
| Q3 25 | $908.0M | $1.5B | ||
| Q2 25 | $555.0M | $1.2B | ||
| Q1 25 | $954.0M | $1.3B | ||
| Q4 24 | $1.1B | $1.3B | ||
| Q3 24 | $818.0M | $1.4B | ||
| Q2 24 | $907.0M | $922.0M |
毛利率DHRTFC
| Q1 26 | 60.3% | — | ||
| Q4 25 | 58.0% | — | ||
| Q3 25 | 58.2% | — | ||
| Q2 25 | 59.3% | — | ||
| Q1 25 | 61.2% | — | ||
| Q4 24 | 59.5% | — | ||
| Q3 24 | 58.7% | — | ||
| Q2 24 | 59.7% | — |
营业利润率DHRTFC
| Q1 26 | 22.6% | — | ||
| Q4 25 | 22.0% | 42.3% | ||
| Q3 25 | 19.1% | 47.9% | ||
| Q2 25 | 12.8% | 42.2% | ||
| Q1 25 | 22.2% | 43.8% | ||
| Q4 24 | 21.8% | 43.3% | ||
| Q3 24 | 16.5% | 47.5% | ||
| Q2 24 | 20.3% | -148.3% |
净利率DHRTFC
| Q1 26 | 17.3% | — | ||
| Q4 25 | 17.5% | 36.6% | ||
| Q3 25 | 15.0% | 40.0% | ||
| Q2 25 | 9.3% | 34.6% | ||
| Q1 25 | 16.6% | 36.0% | ||
| Q4 24 | 16.6% | 35.5% | ||
| Q3 24 | 14.1% | 40.0% | ||
| Q2 24 | 15.8% | 26.1% |
每股收益（稀释后）DHRTFC
| Q1 26 | $1.45 | — | ||
| Q4 25 | $1.69 | $1.01 | ||
| Q3 25 | $1.27 | $1.04 | ||
| Q2 25 | $0.77 | $0.90 | ||
| Q1 25 | $1.32 | $0.87 | ||
| Q4 24 | $1.50 | $0.94 | ||
| Q3 24 | $1.12 | $0.99 | ||
| Q2 24 | $1.22 | $0.62 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | — |
| 总债务越低越好 | — | $42.0B |
| 股东权益账面价值 | — | $65.2B |
| 总资产 | — | $547.5B |
| 负债/权益比越低杠杆越低 | — | 0.64× |
8季度趋势，按日历期对齐
总债务DHRTFC
| Q1 26 | — | — | ||
| Q4 25 | $18.4B | $42.0B | ||
| Q3 25 | $16.9B | $41.7B | ||
| Q2 25 | $17.4B | $44.4B | ||
| Q1 25 | $16.5B | $32.0B | ||
| Q4 24 | $16.0B | $35.0B | ||
| Q3 24 | $17.5B | $36.8B | ||
| Q2 24 | $17.0B | $34.6B |
股东权益DHRTFC
| Q1 26 | — | — | ||
| Q4 25 | $52.5B | $65.2B | ||
| Q3 25 | $51.1B | $65.6B | ||
| Q2 25 | $52.3B | $64.8B | ||
| Q1 25 | $50.8B | $64.6B | ||
| Q4 24 | $49.5B | $63.7B | ||
| Q3 24 | $51.3B | $65.7B | ||
| Q2 24 | $49.9B | $63.8B |
总资产DHRTFC
| Q1 26 | — | — | ||
| Q4 25 | $83.5B | $547.5B | ||
| Q3 25 | $79.9B | $543.9B | ||
| Q2 25 | $81.6B | $543.8B | ||
| Q1 25 | $79.1B | $535.9B | ||
| Q4 24 | $77.5B | $531.2B | ||
| Q3 24 | $80.6B | $523.4B | ||
| Q2 24 | $78.6B | $519.9B |
负债/权益比DHRTFC
| Q1 26 | — | — | ||
| Q4 25 | 0.35× | 0.64× | ||
| Q3 25 | 0.33× | 0.64× | ||
| Q2 25 | 0.33× | 0.69× | ||
| Q1 25 | 0.32× | 0.50× | ||
| Q4 24 | 0.32× | 0.55× | ||
| Q3 24 | 0.34× | 0.56× | ||
| Q2 24 | 0.34× | 0.54× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3B | $2.6B |
| 自由现金流经营现金流 - 资本支出 | $1.1B | — |
| 自由现金流率自由现金流/营收 | 18.2% | — |
| 资本支出强度资本支出/营收 | 4.0% | — |
| 现金转化率经营现金流/净利润 | 1.28× | 1.91× |
| 过去12个月自由现金流最近4个季度 | $5.3B | — |
8季度趋势，按日历期对齐
经营现金流DHRTFC
| Q1 26 | $1.3B | — | ||
| Q4 25 | $2.1B | $2.6B | ||
| Q3 25 | $1.7B | $1.5B | ||
| Q2 25 | $1.3B | $914.0M | ||
| Q1 25 | $1.3B | $746.0M | ||
| Q4 24 | $2.0B | $775.0M | ||
| Q3 24 | $1.5B | $1.5B | ||
| Q2 24 | $1.4B | $845.0M |
自由现金流DHRTFC
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.7B | — | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $1.1B | — |
自由现金流率DHRTFC
| Q1 26 | 18.2% | — | ||
| Q4 25 | 25.5% | — | ||
| Q3 25 | 22.6% | — | ||
| Q2 25 | 18.4% | — | ||
| Q1 25 | 18.4% | — | ||
| Q4 24 | 23.0% | — | ||
| Q3 24 | 21.0% | — | ||
| Q2 24 | 19.7% | — |
资本支出强度DHRTFC
| Q1 26 | 4.0% | — | ||
| Q4 25 | 5.4% | — | ||
| Q3 25 | 4.8% | — | ||
| Q2 25 | 4.2% | — | ||
| Q1 25 | 4.3% | — | ||
| Q4 24 | 7.9% | — | ||
| Q3 24 | 5.1% | — | ||
| Q2 24 | 5.0% | — |
现金转化率DHRTFC
| Q1 26 | 1.28× | — | ||
| Q4 25 | 1.77× | 1.91× | ||
| Q3 25 | 1.83× | 1.03× | ||
| Q2 25 | 2.41× | 0.74× | ||
| Q1 25 | 1.36× | 0.59× | ||
| Q4 24 | 1.86× | 0.61× | ||
| Q3 24 | 1.85× | 1.06× | ||
| Q2 24 | 1.56× | 0.92× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
